|
1
|
Li J, Li P, Zhang G, Qin P, Zhang D and
Zhao W: CircRNA TADA2A relieves idiopathic pulmonary fibrosis by
inhibiting proliferation and activation of fibroblasts. Cell Death
Dis. 11:5532020.
|
|
2
|
Hong SH, Yun B, Cho S, Hong OY, Lee SH,
Kim WH and Hong JY: Loss of ATF3 exacerbates pulmonary fibrosis via
enhanced neutrophil recruitment and profibrotic macrophage
polarization. Clin Sci (Lond). 140:179–199. 2026.
|
|
3
|
Xu Q, Cheng D, Li G, Liu Y, Li P, Sun W,
Ma D and Ni C: CircHIPK3 regulates pulmonary fibrosis by
facilitating glycolysis in miR-30a-3p/FOXK2-dependent manner. Int J
Biol Sci. 17:2294–2307. 2021.
|
|
4
|
Li J, Zhai X, Sun X, Cao S, Yuan Q and
Wang J: Metabolic reprogramming of pulmonary fibrosis. Front
Pharmacol. 13:10318902022.
|
|
5
|
Richeldi L, Baldi F, Pasciuto G, Macagno F
and Panico L: Current and future idiopathic pulmonary fibrosis
therapy. Am J Med Sci. 357:370–373. 2019.
|
|
6
|
Koudstaal T and Wijsenbeek MS: Idiopathic
pulmonary fibrosis. Presse Med. 52:1041662023.
|
|
7
|
Bueno M, Calyeca J, Rojas M and Mora AL:
Mitochondria dysfunction and metabolic reprogramming as drivers of
idiopathic pulmonary fibrosis. Redox Biol. 33:1015092020.
|
|
8
|
Li Z, Sun C and Qin Z: Metabolic
reprogramming of cancer-associated fibroblasts and its effect on
cancer cell reprogramming. Theranostics. 11:8322–8336. 2021.
|
|
9
|
Lv S, Cao M, Luo J, Fu K and Yuan W:
Search progress of pyruvate kinase M2 (PKM2) in organ fibrosis. Mol
Biol Rep. 51:3892024.
|
|
10
|
Vander Heiden MG, Cantley LC and Thompson
CB: Understanding the Warburg effect: The metabolic requirements of
cell proliferation. Science. 324:1029–1033. 2009.
|
|
11
|
Chen TJ, Wu CH, Hung MC, Wang WC and Kung
HJ: Nuclear PKM2: A signal receiver, a gene programmer, and a
metabolic modulator. J Biomed Sci. 32:752025.
|
|
12
|
Israelsen WJ and Vander Heiden MG:
Pyruvate kinase: Function, regulation and role in cancer. Semin
Cell Dev Biol. 43:43–51. 2015.
|
|
13
|
Dayton TL, Jacks T and Vander Heiden MG:
PKM2, cancer metabolism, and the road ahead. EMBO Rep.
17:1721–1730. 2016.
|
|
14
|
Christofk HR, Vander Heiden MG, Harris MH,
Ramanathan A, Gerszten RE, Wei R, Fleming MD, Schreiber SL and
Cantley LC: The M2 splice isoform of pyruvate kinase is important
for cancer metabolism and tumour growth. Nature. 452:230–233.
2008.
|
|
15
|
Zhang Z, Zheng L, Chen Y, Chen Y, Hou J,
Xiao C, Zhu X, Zhao SM and Xiong JW: AARS2 ameliorates myocardial
ischemia via fine-tuning PKM2-mediated metabolism. Elife.
13:RP996702025.
|
|
16
|
Gao S, Li X, Jiang Q, Liang Q, Zhang F, Li
S, Zhang R, Luan J, Zhu J, Gu X, et al: PKM2 promotes pulmonary
fibrosis by stabilizing TGF-β1 receptor I and enhancing TGF-β1
signaling. Sci Adv. 8:eabo09872022.
|
|
17
|
Chen Y, Bai X, Chen J, Huang M, Hong Q,
Ouyang Q, Sun X, Zhang Y, Liu J, Wang X, et al: Pyruvate kinase M2
regulates kidney fibrosis through pericyte glycolysis during the
progression from acute kidney injury to chronic kidney disease.
Cell Prolif. 57:e135482024.
|
|
18
|
Liu H, Takagaki Y, Kumagai A, Kanasaki K
and Koya D: The PKM2 activator TEPP-46 suppresses kidney fibrosis
via inhibition of the EMT program and aberrant glycolysis
associated with suppression of HIF-1α accumulation. J Diabetes
Investig. 12:697–709. 2021.
|
|
19
|
Zheng D, Jiang Y, Qu C, Yuan H, Hu K, He
L, Chen P, Li J, Tu M, Lin L, et al: Pyruvate kinase M2
tetramerization protects against hepatic stellate cell activation
and liver fibrosis. Am J Pathol. 190:2267–2281. 2020.
|
|
20
|
Rao J, Wang H, Ni M, Wang Z, Wang Z, Wei
S, Liu M, Wang P, Qiu J, Zhang L, et al: FSTL1 promotes liver
fibrosis by reprogramming macrophage function through modulating
the intracellular function of PKM2. Gut. 71:2539–2550. 2022.
|
|
21
|
Xu Y, Ma X, Ni W, Zheng L, Lin Z, Lai Y,
Yang N, Dai Z, Yao T, Chen Z, et al: PKM2-driven lactate
overproduction triggers endothelial-to-mesenchymal transition in
ischemic flap via mediating TWIST1 lactylation. Adv Sci (Weinh).
11:e24061842024.
|
|
22
|
Zhang Z, Tan M, Xie Z, Dai L, Chen Y and
Zhao Y: Identification of lysine succinylation as a new
post-translational modification. Nat Chem Biol. 7:58–63. 2011.
|
|
23
|
Wang Z, Zhang Z, Ping Z, Yang S, Li Y,
Jiang T, Zheng X, Zhang Q, Liu Z, Zhang X, et al: Succinate-driven
PKM2 succinylation and dimerization accelerates age-associated
cardiac fibrosis. Commun Biol. 9:6332025.
|
|
24
|
Wang F, Wang K, Xu W, Zhao S, Ye D, Wang
Y, Xu Y, Zhou L, Chu Y, Zhang C, et al: SIRT5 desuccinylates and
activates pyruvate kinase M2 to block macrophage IL-1β production
and to prevent DSS-induced colitis in mice. Cell Rep. 19:2331–2344.
2017.
|
|
25
|
Du J, Zhou Y, Su X, Yu JJ, Khan S, Jiang
H, Kim J, Woo J, Kim JH, Choi BH, et al: Sirt5 is a NAD-dependent
protein lysine demalonylase and desuccinylase. Science.
334:806–809. 2011.
|
|
26
|
Zhang L, Lv T, Hou P, Jin Y and Jia F:
Sirt5-mediated polarization and metabolic reprogramming of
macrophage sustain brain function following ischemic stroke. Brain
Res. 1857:1496132025.
|
|
27
|
Zhao Q, Jing Y, Jiang X, Zhang X, Liu F,
Huang H, Zhang Z, Wang H, Sun S, Ma S, et al: SIRT5 safeguards
against primate skeletal muscle ageing via desuccinylation of TBK1.
Nat Metab. 7:556–573. 2025.
|
|
28
|
Song Z, Zhou M, Lin J, You J and Huang C:
Translatable circular RNAs: Mechanism, function and clinical
application. Int J Biol Macromol. 335:1491852026.
|
|
29
|
Huang A, Zheng H, Wu Z, Chen M and Huang
Y: Circular RNA-protein interactions: Functions, mechanisms, and
identification. Theranostics. 10:3503–3517. 2020.
|
|
30
|
Dong J, Zeng Z, Huang Y, Chen C, Cheng Z
and Zhu Q: Challenges and opportunities for circRNA identification
and delivery. Crit Rev Biochem Mol Biol. 58:19–35. 2023.
|
|
31
|
Chen LL: The expanding regulatory
mechanisms and cellular functions of circular RNAs. Nat Rev Mol
Cell Biol. 21:475–490. 2020.
|
|
32
|
Rochow H, Franz A, Jung M, Weickmann S,
Ralla B, Kilic E, Stephan C, Fendler A and Jung K: Instability of
circular RNAs in clinical tissue samples impairs their reliable
expression analysis using RT-qPCR: From the myth of their advantage
as biomarkers to reality. Theranostics. 10:9268–9279. 2020.
|
|
33
|
Liu B, Liu W, Li H, Zhai N, Lv C, Song X
and Yang S: circ0066187 promotes pulmonary fibrogenesis through
targeting STAT3-mediated metabolism signal pathway. Cell Mol Life
Sci. 82:792025.
|
|
34
|
You Q, Yu J, Pan R, Feng J, Guo H and Liu
B: Decoding the regulatory roles of circular RNAs in cardiac
fibrosis. Noncoding RNA Res. 11:115–130. 2024.
|
|
35
|
Zhou WY, Cai ZR, Liu J, Wang DS, Ju HQ and
Xu RH: Circular RNA: Metabolism, functions and interactions with
proteins. Mol Cancer. 19:1722020.
|
|
36
|
Shen Y, Zhang N, Chai J, Wang T, Ma C, Han
L and Yang M: CircPDIA4 induces gastric cancer progression by
promoting ERK1/2 activation and enhancing biogenesis of oncogenic
circRNAs. Cancer Res. 83:538–552. 2023.
|
|
37
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
|
|
38
|
Wang Y, Zhao Y, Cao G, Jiang M, Yuan X, Li
H, Song X, Zhang J, Lv C and Zhang S: STAT3 facilitates super
enhancer formation to promote fibroblast-to-myofibroblast
differentiation by the analysis of ATAC-Seq, RNA-Seq and ChIP-Seq.
J Cell Mol Med. 29:e706392025.
|
|
39
|
Zhang J, Wang H, Chen H, Li H, Xu P, Liu
B, Zhang Q, Lv C and Song X: ATF3-activated accelerating effect of
LINC00941/lncIAPF on fibroblast-to-myofibroblast differentiation by
blocking autophagy depending on ELAVL1/HuR in pulmonary fibrosis.
Autophagy. 18:2636–2655. 2022.
|
|
40
|
Xiang T, Wang X, Huang S, Zhou K, Fei S,
Zhou B, Yue K, Li Q, Xue S, Dai Y, et al: Inhibition of PKM2 by
shikonin impedes TGF-β1 expression by repressing histone
lactylation to alleviate renal fibrosis. Phytomedicine.
136:1563242025.
|
|
41
|
Liu JY, Liao W, Chen ZY, Liu T, Wang R,
Gong JP, Xu XS and Wu H: PKM2 drives lactate-mediated fibrosis in
liver transplantation. Transplantation. 109:e631–e646. 2025.
|
|
42
|
Wang Y, Hu R, Zhang X, Cai G, Ding Q and
Che P: PKM2 mediates the glycolytic response to matrix stiffness in
lung fibroblasts. Front Cell Dev Biol. 14:17710782026.
|
|
43
|
Feng J, Huang X, Peng Y, Yang W, Yang X,
Tang R, Xu Q, Gao Y, He Z, Xing S and Mei S: Pyruvate kinase M2
modulates mitochondrial dynamics and EMT in alveolar epithelial
cells during sepsis-associated pulmonary fibrosis. J Transl Med.
23:2052025.
|
|
44
|
Gélabert C, Papoutsoglou P, Golán I,
Ahlström E, Ameur A, Heldin CH, Caja L and Moustakas A: The long
non-coding RNA LINC00707 interacts with Smad proteins to regulate
TGFβ signaling and cancer cell invasion. Cell Commun Signal.
21:2712023.
|
|
45
|
Chiusa M, Lee YA, Zhang MZ, Harris RC,
Sherrill T, Lindner V, Brooks CR, Yu G, Fogo AB, Flynn CR, et al:
Cytoplasmic retention of the DNA/RNA-binding protein FUS
ameliorates organ fibrosis in mice. J Clin Invest.
134:e1751582024.
|
|
46
|
Di Timoteo G, Dattilo D, Centrón-Broco A,
Colantoni A, Guarnacci M, Rossi F, Incarnato D, Oliviero S, Fatica
A, Morlando M and Bozzoni I: Modulation of circRNA metabolism by
m6A modification. Cell Rep. 31:1076412020.
|
|
47
|
Luo S, Ye D, Zhang Y, Wang Y, Zhou M, Lv
M, Wang X, Zhong K, Zhang Y, Hu L, et al: S-Nitrosylation of
pyruvate kinase isoform 2 drives cardiac fibrosis by promoting
mitochondrial fission. Circulation. 153:338–357. 2026.
|
|
48
|
Wu Y, Tang L, Huang H, Yu Q, Hu B, Wang G,
Ge F, Yin T, Li S and Yu X: Phosphoglycerate dehydrogenase
activates PKM2 to phosphorylate histone H3T11 and attenuate
cellular senescence. Nat Commun. 14:13232023.
|
|
49
|
Yu JT, Xie SS, Shen XY, Li Z, Hu XW, Zhang
Y, Dong ZH, Wang JN, Li XY, Dong YH, et al: Renal tubular
epithelial IGFBP7 interacts with PKM2 to drive renal lipid
accumulation and fibrosis. Mol Ther. 33:3757–3777. 2025.
|
|
50
|
Wang J, Gao J, Ding L, Yang X, Zheng D,
Zeng Y, Zhu J, Lei W, Chen C, Liu Z and Huang JA: Circular
RNA-cacna1d plays a critical role in sepsis-induced lung injury by
sponging microRNA-185-5p. Am J Respir Cell Mol Biol. 72:181–194.
2025.
|
|
51
|
Sandoval JE, Carullo NVN, Salisbury AJ,
Day JJ and Reich NO: Mechanism of non-coding RNA regulation of
DNMT3A. Epigenetics Chromatin. 18:152025.
|
|
52
|
He R, Hu C, Yuan Y, Li T, Tian Q, Huang T,
Lin Q, Zheng S, Chen C, Fu Z and Chen R: Glycolysis reprogramming
in CAFs promotes oxaliplatin resistance in pancreatic cancer
through circABCC4 mediated PKM2 nuclear translocation. Cell Death
Dis. 16:1262025.
|
|
53
|
Fei M, Li X, Liang S, Zhou S, Wu H, Sun L,
Liu Y, Hu Q, Liu L and Wang J: LncRNA PWRN1 inhibits the
progression of hepatocellular carcinoma by activating PKM2
activity. Cancer Lett. 584:2166202024.
|
|
54
|
Yang W, Xia Y, Ji H, Zheng Y, Liang J,
Huang W, Gao X, Aldape K and Lu Z: Nuclear PKM2 regulates β-catenin
transactivation upon EGFR activation. Nature. 480:118–122.
2011.
|
